Prof. Lorraine O’Driscoll appointed Research Lead Trinity St. James' Cancer Institute
Congratulations to Prof. Lorraine O’Driscoll FTCD, FRSB, MRIA who has recently been announced as Research Lead for Trinity St James's Cancer Institute (TSJCI).
The role was previously held by Prof. John O’Leary Consultant Pathologist and more recently Prof. Orla Sheils, now Vice Provost of Trinity College Dublin (TCD).
TSJCI, the first of its kind in Ireland, builds on the long tradition of outstanding comprehensive cancer care delivered at Ireland's largest academic health campus at St James's Hospital, with the research and educational excellence of Trinity College Dublin. It is the first Irish cancer institute to be accredited by the Organisation of European Cancer Institutes (OECI). The OECI mission is to foster high quality comprehensive cancer care, research and education; with the aim of improving patient outcomes throughout Europe.
TSJCI’s mission is to integrate innovative and ground-breaking cancer science with compassionate, multidisciplinary, patient-focused clinical care through translation of key research findings into advances in the prevention, diagnosis and treatment of cancer. These goals will be achieved by utilizing the extensive resources located on the St James’s campus, allied with the research and educational expertise of TCD, and in partnership with the wider cancer care community. TSJCI will continue to work across academia, and will align the efforts of government, industry, philanthropy, and patient groups. Ultimately, the Institute will provide national leadership to decrease cancer mortality and continuously improve the cancer patient's experience and outcome.
- 2020 News Archive
- 2019 News Archive
- 2018 News Archive
- 2017 News Archive
- 2016 News Archive
- 2015 News Archive
- 2014 News Archive
- 2013 News Archive
- 2012 News Archive
- 2009-2011 News Archive